Despite challenges posed by COVID-19, West had a strong first quarter, with 13% organic sales growth and double-digit growth in adjusted earnings per share. The company's financial position remains strong, with $633.1 million in working capital and $335.3 million in cash on hand. Full-year guidance includes estimated sales of $1.95 billion to $1.97 billion and adjusted earnings per share of $3.52 to $3.62, with expected organic sales growth of 8%. West remains committed to meeting the increased demand for its products, particularly in support of COVID-19 solutions, and is confident in its long-term growth strategy.